Cargando…

Artificial Intelligence based Models for Screening of Hematologic Malignancies using Cell Population Data

Cell Population Data (CPD) provides various blood cell parameters that can be used for differential diagnosis. Data analytics using Machine Learning (ML) have been playing a pivotal role in revolutionizing medical diagnostics. This research presents a novel approach of using ML algorithms for screen...

Descripción completa

Detalles Bibliográficos
Autores principales: Syed-Abdul, Shabbir, Firdani, Rianda-Putra, Chung, Hee-Jung, Uddin, Mohy, Hur, Mina, Park, Jae Hyeon, Kim, Hyung Woo, Gradišek, Anton, Dovgan, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075908/
https://www.ncbi.nlm.nih.gov/pubmed/32179774
http://dx.doi.org/10.1038/s41598-020-61247-0
_version_ 1783507113083928576
author Syed-Abdul, Shabbir
Firdani, Rianda-Putra
Chung, Hee-Jung
Uddin, Mohy
Hur, Mina
Park, Jae Hyeon
Kim, Hyung Woo
Gradišek, Anton
Dovgan, Erik
author_facet Syed-Abdul, Shabbir
Firdani, Rianda-Putra
Chung, Hee-Jung
Uddin, Mohy
Hur, Mina
Park, Jae Hyeon
Kim, Hyung Woo
Gradišek, Anton
Dovgan, Erik
author_sort Syed-Abdul, Shabbir
collection PubMed
description Cell Population Data (CPD) provides various blood cell parameters that can be used for differential diagnosis. Data analytics using Machine Learning (ML) have been playing a pivotal role in revolutionizing medical diagnostics. This research presents a novel approach of using ML algorithms for screening hematologic malignancies using CPD. The data collection was done at Konkuk University Medical Center, Seoul. A total of (882 cases: 457 hematologic malignancy and 425 hematologic non-malignancy) were used for analysis. In our study, seven machine learning models, i.e., SGD, SVM, RF, DT, Linear model, Logistic regression, and ANN, were used. In order to measure the performance of our ML models, stratified 10-fold cross validation was performed, and metrics, such as accuracy, precision, recall, and AUC were used. We observed outstanding performance by the ANN model as compared to other ML models. The diagnostic ability of ANN achieved the highest accuracy, precision, recall, and AUC ± Standard Deviation as follows: 82.8%, 82.8%, 84.9%, and 93.5% ± 2.6 respectively. ANN algorithm based on CPD appeared to be an efficient aid for clinical laboratory screening of hematologic malignancies. Our results encourage further work of applying ML to wider field of clinical practice.
format Online
Article
Text
id pubmed-7075908
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70759082020-03-23 Artificial Intelligence based Models for Screening of Hematologic Malignancies using Cell Population Data Syed-Abdul, Shabbir Firdani, Rianda-Putra Chung, Hee-Jung Uddin, Mohy Hur, Mina Park, Jae Hyeon Kim, Hyung Woo Gradišek, Anton Dovgan, Erik Sci Rep Article Cell Population Data (CPD) provides various blood cell parameters that can be used for differential diagnosis. Data analytics using Machine Learning (ML) have been playing a pivotal role in revolutionizing medical diagnostics. This research presents a novel approach of using ML algorithms for screening hematologic malignancies using CPD. The data collection was done at Konkuk University Medical Center, Seoul. A total of (882 cases: 457 hematologic malignancy and 425 hematologic non-malignancy) were used for analysis. In our study, seven machine learning models, i.e., SGD, SVM, RF, DT, Linear model, Logistic regression, and ANN, were used. In order to measure the performance of our ML models, stratified 10-fold cross validation was performed, and metrics, such as accuracy, precision, recall, and AUC were used. We observed outstanding performance by the ANN model as compared to other ML models. The diagnostic ability of ANN achieved the highest accuracy, precision, recall, and AUC ± Standard Deviation as follows: 82.8%, 82.8%, 84.9%, and 93.5% ± 2.6 respectively. ANN algorithm based on CPD appeared to be an efficient aid for clinical laboratory screening of hematologic malignancies. Our results encourage further work of applying ML to wider field of clinical practice. Nature Publishing Group UK 2020-03-16 /pmc/articles/PMC7075908/ /pubmed/32179774 http://dx.doi.org/10.1038/s41598-020-61247-0 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Syed-Abdul, Shabbir
Firdani, Rianda-Putra
Chung, Hee-Jung
Uddin, Mohy
Hur, Mina
Park, Jae Hyeon
Kim, Hyung Woo
Gradišek, Anton
Dovgan, Erik
Artificial Intelligence based Models for Screening of Hematologic Malignancies using Cell Population Data
title Artificial Intelligence based Models for Screening of Hematologic Malignancies using Cell Population Data
title_full Artificial Intelligence based Models for Screening of Hematologic Malignancies using Cell Population Data
title_fullStr Artificial Intelligence based Models for Screening of Hematologic Malignancies using Cell Population Data
title_full_unstemmed Artificial Intelligence based Models for Screening of Hematologic Malignancies using Cell Population Data
title_short Artificial Intelligence based Models for Screening of Hematologic Malignancies using Cell Population Data
title_sort artificial intelligence based models for screening of hematologic malignancies using cell population data
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075908/
https://www.ncbi.nlm.nih.gov/pubmed/32179774
http://dx.doi.org/10.1038/s41598-020-61247-0
work_keys_str_mv AT syedabdulshabbir artificialintelligencebasedmodelsforscreeningofhematologicmalignanciesusingcellpopulationdata
AT firdaniriandaputra artificialintelligencebasedmodelsforscreeningofhematologicmalignanciesusingcellpopulationdata
AT chungheejung artificialintelligencebasedmodelsforscreeningofhematologicmalignanciesusingcellpopulationdata
AT uddinmohy artificialintelligencebasedmodelsforscreeningofhematologicmalignanciesusingcellpopulationdata
AT hurmina artificialintelligencebasedmodelsforscreeningofhematologicmalignanciesusingcellpopulationdata
AT parkjaehyeon artificialintelligencebasedmodelsforscreeningofhematologicmalignanciesusingcellpopulationdata
AT kimhyungwoo artificialintelligencebasedmodelsforscreeningofhematologicmalignanciesusingcellpopulationdata
AT gradisekanton artificialintelligencebasedmodelsforscreeningofhematologicmalignanciesusingcellpopulationdata
AT dovganerik artificialintelligencebasedmodelsforscreeningofhematologicmalignanciesusingcellpopulationdata